Works matching IS 09509232 AND DT 2015 AND VI 34 AND IP 16
Results: 13
Stem cell programs are retained in human leukemic lymphoblasts.
- Published in:
- Oncogene, 2015, v. 34, n. 16, p. 2083, doi. 10.1038/onc.2014.148
- By:
- Publication type:
- Article
CXCL12-γ in primary tumors drives breast cancer metastasis.
- Published in:
- Oncogene, 2015, v. 34, n. 16, p. 2043, doi. 10.1038/onc.2014.157
- By:
- Publication type:
- Article
The ets transcription factor Fli-1 in development, cancer and disease.
- Published in:
- Oncogene, 2015, v. 34, n. 16, p. 2022, doi. 10.1038/onc.2014.162
- By:
- Publication type:
- Article
Targeted resequencing of the microRNAome and 3′UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer.
- Published in:
- Oncogene, 2015, v. 34, n. 16, p. 2125, doi. 10.1038/onc.2014.117
- By:
- Publication type:
- Article
SIRT3 regulates cellular iron metabolism and cancer growth by repressing iron regulatory protein 1.
- Published in:
- Oncogene, 2015, v. 34, n. 16, p. 2115, doi. 10.1038/onc.2014.124
- By:
- Publication type:
- Article
c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT.
- Published in:
- Oncogene, 2015, v. 34, n. 16, p. 2072, doi. 10.1038/onc.2014.152
- By:
- Publication type:
- Article
Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression in macrophages.
- Published in:
- Oncogene, 2015, v. 34, n. 16, p. 2052, doi. 10.1038/onc.2014.154
- By:
- Publication type:
- Article
TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells.
- Published in:
- Oncogene, 2015, v. 34, n. 16, p. 2138, doi. 10.1038/onc.2014.156
- By:
- Publication type:
- Article
Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3.
- Published in:
- Oncogene, 2015, v. 34, n. 16, p. 2032, doi. 10.1038/onc.2014.146
- By:
- Publication type:
- Article
KSR1 regulates BRCA1 degradation and inhibits breast cancer growth.
- Published in:
- Oncogene, 2015, v. 34, n. 16, p. 2103, doi. 10.1038/onc.2014.129
- By:
- Publication type:
- Article
PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling.
- Published in:
- Oncogene, 2015, v. 34, n. 16, p. 2061, doi. 10.1038/onc.2014.153
- By:
- Publication type:
- Article
Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies.
- Published in:
- Oncogene, 2015, v. 34, n. 16, p. 2011, doi. 10.1038/onc.2014.155
- By:
- Publication type:
- Article
Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer.
- Published in:
- Oncogene, 2015, v. 34, n. 16, p. 2094, doi. 10.1038/onc.2014.144
- By:
- Publication type:
- Article